AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
May 30 2022
News
Paxlovid Becomes Household Name for Covid-19 Patients
The Covid-19 treatment from Pfizer Inc. has become the leading pandemic pill prescribed in the U.S., as supplies have improved and its availability at pharmacies widened.
Pfizer’s antiviral drug, called Paxlovid, totaled more than 412,000 prescriptions through May 6, compared with about 110,000 prescriptions of molnupiravir, an antiviral from Merck & Co. and Ridgeback
Wall Street Journal (News)Dec 19 2021
News
Indian Pharmaceutical Manufacturers Are Ready To Bring Covid Antivirals To The World
Covid-19 cases were already beginning to surge around the world before scientists in South Africa identified the omicron variant. Two Covid antiviral treatments developed by Merck and Pfizer are seen by some public health officials as key to controlling renewed outbreaks, especially for areas that lack access to vaccines or face large numbers of people who refuse to take them. Several Indian
ForbesMar 10 2021
News
Biden to order 100 million more doses of Johnson & Johnson vaccine
President Joe Biden will announce Wednesday that the United States plans to order another 100 million Covid-19 vaccine doses from Johnson & Johnson, according to two officials familiar with the decision.
Biden is set to meet Wednesday afternoon with the pharmaceutical company and its production partner, Merck.
The planned purchase would bring the country's total vaccine order
PoliticoDec 27 2021
News
Experts Warn Pfizer Antiviral Pills May Pose Risks With Other Medications
Experts warn that despite the first antiviral pills for COVID-19 promising protection for those at risk of severe disease, Pfizer's or Merck's new medications may not be safe for everyone, NBC News reported over the weekend.
One of the two drugs in Pfizer's Paxlovid antiviral cocktail could cause severe or life-threatening interactions with commonly used medications, including statins,
Newsmax (News)Aug 18 2020
Data
What Is It Like to Work With Androids?
Last summer, the €16 billion science and technology company Merck KGaA, Darmstadt, Germany, brought in an HR specialist named Elenoide to handle employee development questions at HQ.
Brought, not hired. Elenoide is an android, a carefully crafted work of robotics capable of some of the most advanced AI known to HR tech.
Elenoide isn't meant to replace or even supplement the
GallupAug 15 2017
News
Charlottesville: CEOs quit Trump council over response to violence
Bosses from Intel, Merck and Under Armour distance themselves from administration after president’s reluctance to denounce white nationalists
The GuardianDec 27 2021
News
Pfizer antiviral pills may be risky with other medications
As the omicron surge pummels a pandemic-weary nation, the first antiviral pills for Covid-19 promise desperately needed protection for people at risk of severe disease. However, many people prescribed Pfizer’s or Merck’s new medications will require careful monitoring by doctors and pharmacists, and the antivirals may not be safe for everyone, experts caution.
The Food and Drug
NBC News DigitalMar 21 2022
News
Doctors finding hurdles to using pills to treat COVID-19
High-risk COVID-19 patients now have new treatments they can take at home to stay out of the hospital — if doctors get the pills to them fast enough.
Health systems around the country are rushing out same-day prescription deliveries. Some clinics have started testing and treating patients in one visit, an initiative that President Joe Biden’s administration recently touted.
The
Associated PressFeb 07 2022
News
Pharmacies feel stiffed on COVID pill payments
Some pharmacies are getting paid as little as $1 to dispense the COVID antiviral pills made by Pfizer and Merck.
Why it matters: Most pharmacies want to offer the drugs, especially the one from Pfizer that drastically cuts the odds of hospitalization and death. But low payments could hurt Americans' ability to access the pills in some areas if pharmacies decide they can't afford to
AxiosNov 16 2021
News
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries
Pfizer announced a deal on Tuesday to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer nations that are home to more than half of the world’s population.
The agreement follows a similar arrangement negotiated by Merck last month, and together the deals have the potential to vastly expand global production of two simple antiviral pills that could
New York Times (News)